AIM ImmunoTech Inc.

AIM ImmunoTech Inc.verified

AIM

Price:

$1.47

Market Cap:

$4.19M

AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, prostate and pancreatic cancer, myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. In addition, the company provides Alferon N Injection, an injectable formulation of nat...[Read more]

Industry

Biotechnology

IPO Date

1996-07-12

Stock Exchange

AMEX

Ticker

AIM

The Enterprise Value as of December 2025 (TTM) for AIM ImmunoTech Inc. (AIM) is 4.19M

According to AIM ImmunoTech Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.19M. This represents a change of -99.16% compared to the average of 499.60M of the last 4 quarters.

AIM ImmunoTech Inc. (AIM) Historical Enterprise Value (quarterly & annually)

How has AIM Enterprise Value performed in the past?

The mean historical Enterprise Value of AIM ImmunoTech Inc. over the last ten years is 2.01B. The current 4.19M Enterprise Value has changed -79.18% with respect to the historical average. Over the past ten years (40 quarters), AIM's Enterprise Value was at its highest in in the March 2021 quarter at 10.33B. The Enterprise Value was at its lowest in in the September 2025 quarter at 5.73M.

Quarterly (TTM)
Annual

Average

2.01B

Median

1.48B

Minimum

201.62M

Maximum

5.66B

AIM ImmunoTech Inc. (AIM) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of AIM ImmunoTech Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 2.71%

Maximum Annual Enterprise Value = 5.66B

Minimum Annual Increase = -74.83%

Minimum Annual Enterprise Value = 201.62M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20241.12B-47.42%
20232.13B45.77%
20221.46B-66.15%
20214.32B-23.67%
20205.66B2.71%
2019201.62M-74.83%
2018801.03M-20.22%
20171.00B-33.20%
20161.50B-20.35%
20151.89B-59.89%

AIM ImmunoTech Inc. (AIM) Average Enterprise Value

How has AIM Enterprise Value performed in the past?

The current Enterprise Value of AIM ImmunoTech Inc. (AIM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

1.57B

5-year avg

2.94B

10-year avg

2.01B

AIM ImmunoTech Inc. (AIM) Enterprise Value vs. Peers

How is AIM’s Enterprise Value compared to its peers?

AIM ImmunoTech Inc.’s Enterprise Value is less than KALA BIO, Inc. (15.62M), less than Oragenics, Inc. (4.58M), greater than Pasithea Therapeutics Corp. (-4114320103.00), greater than VYNE Therapeutics Inc. (-13109994.00), less than Quoin Pharmaceuticals, Ltd. (9.45M), greater than Ensysce Biosciences, Inc. (2.58M), less than XTL Biopharmaceuticals Ltd. (7.96M), less than Alaunos Therapeutics, Inc. (6.07M), less than Can-Fite BioPharma Ltd. (9.51M), less than Soligenix, Inc. (11.75M),

Build a custom stock screener for AIM ImmunoTech Inc. (AIM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AIM ImmunoTech Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AIM ImmunoTech Inc. (AIM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AIM ImmunoTech Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is AIM ImmunoTech Inc.'s Enterprise Value?

What is the highest Enterprise Value for AIM ImmunoTech Inc. (AIM)?

What is the 3-year average Enterprise Value for AIM ImmunoTech Inc. (AIM)?

What is the 5-year average Enterprise Value for AIM ImmunoTech Inc. (AIM)?

How does the current Enterprise Value for AIM ImmunoTech Inc. (AIM) compare to its historical average?